Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases.
Pacher
Pál
P
Ungvári
Zoltán
Z
D050197:Atherosclerosis / Q000473:pathology*; D063385:Cannabinoid Receptor Modulators / Q000502:physiology; D002465:Cell Movement; D002634:Chemotaxis, Leukocyte / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000473:pathology*; D009000:Monocytes / Q000502:physiology*; D043884:Receptor, Cannabinoid, CB1 / Q000502:physiology; D043885:Receptor, Cannabinoid, CB2 / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D063385:Cannabinoid Receptor Modulators; D043884:Receptor, Cannabinoid, CB1; D043885:Receptor, Cannabinoid, CB2; D014409:Tumor Necrosis Factor-alpha